EUCTR2006-002938-38-DE进行中（未招募）不适用
EFFECT OF ERYTHROPOIETIN ON RENAL FUNCTION AFTER KIDNEY TRANSPLANTATION - EPO AND ISCHEMIA-REPERFUSION AFTER KIDNEY TRANSPLANTATIO
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •written informed consent
- •male or female gender
- •age between 18 and 70 years
- •cadaveric kidney transplantion
- •cold ischemia time below 24 hours prior to transplantation of the kidney
- •treatment with standard immunosupressive agents after transplantation
- •HbA1C below 9% in patients with diabetes mellitus
- •hemoglobin >8 g/dl und <16 g/dl prior to kidney transplantation
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •myelodyplastic syndrome or proliferative disease
- •cancer within 5 years prior to kidney transplantation
- •advanced renal anemia prior to kidney transplantation
- •polyglobulia with persistent hemoglobin >16 g/dl
- •treatment with other growth factors (e.g. GM-CSF)
- •bleeding episodes within 3 month prior to kidney transplantation
- •uncontrolled arterial hypertension
- •known hypersensitivity against rHuEPO
- •cardiovascular event within 6 month prior to kidney transplantation
- •thromembolic event within 6 month prior to kidney transplantation
- •chronic infection and/or persistent high sensitivity CRP >10 mg/l
- •chronic haemolytic disorders (e.g. thalassemia)
- •other organ transplants (e.g. combined pancreas/kidney transplantation)
- •women of childbearing potential without appropriate contraception
- •psychiatric disease or epilepsia
- •participation in another clinical trial within 30 days prior to inclusion
研究者
相似试验
已完成
不适用
Erythopoietin and delayed graft function in renal allografts from extended criteria donorsRenal transplantationSurgeryOther complications of surgical and medical care, not elsewhere classifiedISRCTN85447324Central Manchester and Manchester Children's University Hospital (CMMCUH) NHS Trust (UK)40
进行中（未招募）
1 期
Erythropoietin and Delayed Graft Function in Renal Allografts from Extended Criteria Donors. - EPO and DGFEUCTR2006-005373-22-GBCentral Manchester and Manchester Children's University Hospitals NHS Trust40
已完成
不适用
Erythropoeitin effect on Chronic Kidney DiseaseChronic Kidney Disease.Kidney damage with mild decreased GFR (60-89 mL/min)IRCT2016043027686N1Zahedan University of Medical Sciences60
Unknown
1 期
The Effect of Erythropoietin Usage in Renal Function After Kidney Transplantation, in Early Phase, in Contrast to Placebo GroupTransplantation, KidneyNCT00617474Labbafinejhad Hospital50
已完成
2 期
Erythropoietin (EPO) and Ischemia-reperfusion After Kidney TransplantationKidney TransplantationNCT00425698Hannover Medical School88